infiltration anesthetic efficacy of 1.8 ml and 3.6 ml of articaine for mandibular incisor in irreversible pulpitis

Comparation of infiltration anesthetic efficacy of 1.8 ml and 3.6 ml of articaine for mandibular incisor in irreversible pulpitis: A randomized clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

IRCT

Registry ID

IRCT20091213002847N4

Enrollment

Registered

2023-07-22

Start date

2023-04-05

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain during root canal treatment.

Interventions

Intervention 1: 1st Intervention group: The infiltration involved adeposition of 1.8 mL articaine (Xilonibsa, Inibsa, Barcelona, Spain) each patient received 1 cartridges of the anesthetic solution. T

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Healthy patients With Mandibular Incisor teeth with irreversible pulpitis and normal Periapical Radiography Without Spontaneous pain that required Emergency treatment

Exclusion criteria

Exclusion criteria: History of sensitivity to 4%articaine or epinephrine Systemic diseases Pregnancy or breastfeeding Any type of medication that could potentially interact with the anesthetic solution Spontaneous pain Periodontal disease or unable to get restoration Having analgesic late 12 hours

Design outcomes

Primary

Measure	Time frame
Pain during root canal treatment. Timepoint: During the preparation of the access hole, entering the dentin, entering the pulp chamber or placing the file in the canal. Method of measurement: VAS.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Mahdi Yaaghooti Khorasani

Rafsanjan University of Medical Sciences

m.yaghooti@yahoo.com+98 34 3428 0040

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026